Showing results (1-10 of 224) with videos related to
Sort By:
Pageof 23
Rheumatology (Oxford, England)|June 22, 2012
Developing an effective treatment algorithm for rheumatoid arthritisEdward C Keystone, Josef Smolen, Piet van RielThe Journal of Rheumatology|May 17, 2011
Does anti-tumor necrosis factor-α therapy affect risk of serious infection and cancer in patients with rheumatoid arthritis?: a review of longterm dataEdward C KeystoneCurrent Opinion in Rheumatology|April 23, 2003
Abandoned therapies and unpublished trials in rheumatoid arthritisEdward C KeystoneThe Journal of Rheumatology. Supplement|March 3, 2005
Safety of biologic therapies--an updateEdward C KeystoneNature Clinical Practice. Rheumatology|November 1, 2006
Strategies to control disease in rheumatoid arthritis with tumor necrosis factor antagonists-an opportunity to improve outcomesEdward C KeystoneThe Journal of Rheumatology. Supplement|June 11, 2009
Clinical implications of understanding radiographic findings in relation to clinical outcomes in rheumatoid arthritisEdward C KeystoneDrugs of Today (Barcelona, Spain : 1998)|December 12, 2003
Appropriate and effective rheumatoid arthritis control: role of TNF antagonistsEdward C KeystoneExpert Opinion on Drug Safety|March 30, 2005
What to do with TNF failuresEdward C Keystone, Arthur KavanaughRheumatology (Oxford, England)|May 19, 2012
Sustained efficacy of certolizumab pegol added to methotrexate in the treatment of rheumatoid arthritis: 2-year results from the RAPID 1 trialEdward C Keystone, Bernard Combe, Josef Smolen, et al.The Journal of Rheumatology. Supplement|May 4, 2010
Tumor necrosis factor and anti-tumor necrosis factor therapiesEdward C Keystone, Carl F WarePageof 23